DE68911049D1 - Therapeutische Verwendung des Isopropylesterderivates von Monosialogangliosiden bei Erkrankungen des Nervensystems, begleitet von Entzündungen. - Google Patents

Therapeutische Verwendung des Isopropylesterderivates von Monosialogangliosiden bei Erkrankungen des Nervensystems, begleitet von Entzündungen.

Info

Publication number
DE68911049D1
DE68911049D1 DE89113160T DE68911049T DE68911049D1 DE 68911049 D1 DE68911049 D1 DE 68911049D1 DE 89113160 T DE89113160 T DE 89113160T DE 68911049 T DE68911049 T DE 68911049T DE 68911049 D1 DE68911049 D1 DE 68911049D1
Authority
DE
Germany
Prior art keywords
isopropyl ester
ester derivative
monosialogangliosides
inflammation
accompanied
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE89113160T
Other languages
English (en)
Other versions
DE68911049T2 (de
Inventor
Valle Francesco Della
Aurelio Romeo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fidia Farmaceutici SpA
Original Assignee
Fidia SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fidia SpA filed Critical Fidia SpA
Publication of DE68911049D1 publication Critical patent/DE68911049D1/de
Application granted granted Critical
Publication of DE68911049T2 publication Critical patent/DE68911049T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C07H15/10—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical containing unsaturated carbon-to-carbon bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biochemistry (AREA)
  • Rheumatology (AREA)
  • Genetics & Genomics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
DE68911049T 1988-07-19 1989-07-18 Therapeutische Verwendung des Isopropylesterderivates von Monosialogangliosiden bei Erkrankungen des Nervensystems, begleitet von Entzündungen. Expired - Fee Related DE68911049T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8848208A IT1224513B (it) 1988-07-19 1988-07-19 Uso terapeutico del derivato estere isopropilico del monosialogangliosi de in patologie ad interessamento nervoso con componente infiammatoria

Publications (2)

Publication Number Publication Date
DE68911049D1 true DE68911049D1 (de) 1994-01-13
DE68911049T2 DE68911049T2 (de) 1994-06-01

Family

ID=11265246

Family Applications (1)

Application Number Title Priority Date Filing Date
DE68911049T Expired - Fee Related DE68911049T2 (de) 1988-07-19 1989-07-18 Therapeutische Verwendung des Isopropylesterderivates von Monosialogangliosiden bei Erkrankungen des Nervensystems, begleitet von Entzündungen.

Country Status (10)

Country Link
EP (1) EP0351784B1 (de)
JP (1) JPH0278622A (de)
AT (1) ATE97812T1 (de)
AU (1) AU624164B2 (de)
DE (1) DE68911049T2 (de)
DK (1) DK354589A (de)
ES (1) ES2061821T3 (de)
IT (1) IT1224513B (de)
PH (1) PH26117A (de)
ZA (1) ZA895367B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09278653A (ja) * 1996-04-05 1997-10-28 Santen Pharmaceut Co Ltd 網膜疾患治療剤
US6998392B2 (en) 2003-04-02 2006-02-14 Mti Meta Tech Inc. Formulation to treat or prevent parasitic infection
US7851451B2 (en) 2004-03-12 2010-12-14 Mti Meta Tech Inc. Formulations for mediating inflammatory bowel disorders
US8536140B2 (en) 2004-03-12 2013-09-17 Mti Meta Tech Inc. Methods for treating inflammatory bowel disease
CN104490837A (zh) * 2014-12-30 2015-04-08 哈尔滨医科大学科技开发总公司 单唾液酸四己糖神经节苷脂钠的口服制剂

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1199116B (it) * 1984-07-03 1988-12-30 Fidia Farmaceutici Derivati di gangliosidi

Also Published As

Publication number Publication date
PH26117A (en) 1992-02-24
EP0351784B1 (de) 1993-12-01
IT8848208A0 (it) 1988-07-19
EP0351784A3 (en) 1990-12-27
ZA895367B (en) 1990-04-25
JPH0278622A (ja) 1990-03-19
ES2061821T3 (es) 1994-12-16
AU624164B2 (en) 1992-06-04
DE68911049T2 (de) 1994-06-01
DK354589D0 (da) 1989-07-18
AU3819089A (en) 1990-01-25
ATE97812T1 (de) 1993-12-15
IT1224513B (it) 1990-10-04
EP0351784A2 (de) 1990-01-24
DK354589A (da) 1990-01-20

Similar Documents

Publication Publication Date Title
PT716600E (pt) Composicoes para administracao topica contendo derivados do acido 3-benzoilfenilacetico para o tratamento de doencas inflamatorias oftalmicas
DE59108854D1 (de) Arzneimittel sowie deren herstellung und deren verwendung bei der bekämpfung von schmerzen und/oder entzündungen an tieren und menschen
DK0713701T3 (da) 2-Brommelatonin til behandling af søvnforstyrrelser
IE790756L (en) Cerebral therapeutic agent
MC2078A1 (fr) Emploi d'alezastine comme matiere active contre le psoriasis et des maladies inflammatoires
DE68912195D1 (de) Verwendung von Pyrrolicloncarbonsäurealkylestern zur Herstellung eines Arzneimittels zur Behandlung von Ichtyosis.
FI950909A0 (fi) Rasvahappojohdannaisia
ATE89556T1 (de) Naphthalenverbindungen und antiallergische und antiinflammatorische pharmazeutische mittel.
ES2063060T3 (es) Benzamida contra enfermedades cognoscitivas.
EP0315113A3 (de) Innere Ester von Gangliosiden mit analgetisch-entzündungshemmender Aktivität
DE68911049D1 (de) Therapeutische Verwendung des Isopropylesterderivates von Monosialogangliosiden bei Erkrankungen des Nervensystems, begleitet von Entzündungen.
EP0352826A3 (de) Verwendung von 5-Amino-salicylsäure für die Behandlung von Hautkrankheiten
IT9021768A0 (it) Derivato della melatonina ad attivita' terapeutica in dermatologia
IT1189308B (it) L'impiego in terapeutica d'un derivato dell'acetammide
NO974551L (no) Bruk av sulbutiamin for å fremskaffe farmasöytiske sammensetninger nyttige i behandling av visse psykomotoriske- og psyko-intellektuelle sykdommer
DK576687A (da) Terapeutisk aktive alkensyrederivater
DK0673646T3 (da) Anvendelse af deoxyspergualin til fremstilling af et lægemiddel til behandling af inflammatorisk-hyperreaktive sygdomme
IT8548976A0 (it) Composizione di un principio farmaceuticamente attivo e fruttosio per alleviare i sintomi di affezioni da raffreddamento in pazienti diabetici
IT1232963B (it) Composizioni farmaceutiche topiche contenenti antiistaminici h2
IT8629527V0 (it) Cuffia predisposta per fungere da supporto alle cannule per l'irriga zione auricolare nella prova calori ca dell'esame vestibolare
IT8667614A0 (it) Impiego della elastase nel trattamento terapeutico di disturbi della irrorazione sanguigna periferica
IT8309569A0 (it) Applicazione terapeutica di farmaci ad attivita' antiproteolitica speci ficanel trattamento delle ulcere torpide

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: FIDIA FARMACEUTICI S.P.A., ABANO TERME, PADUA/PADO

8339 Ceased/non-payment of the annual fee